Our hypothesis is that besides HLA-DRB1*, other HLA-A* and HLA-B* alleles, especially HLA-B*44, could be novel independent predictors contributing to the strong increase of RF and anti-CCP serum levels in RA patients. This evidence concerns the gene HLA-B and rheumatoid arthritis.